In-house testing for homologous recombination repair deficiency (HRD) testing in ovarian carcinoma: a feasibility study comparing AmoyDx HRD Focus panel with Myriad myChoiceCDx assay

Fumagalli, C; Betella, I; Ranghiero, A; Guerini-Rocco, E; Bonaldo, G; Rappa, A; Vacirca, D; Colombo, N; Barberis, M

Barberis, M (通讯作者),Ist Ricovero & Cura Carattere Sci IRCCS, European Inst Oncol IEO, Clin Unit Oncogen, I-20141 Milan, Italy.

PATHOLOGICA, 2022; 114 (4): 288

Abstract

Background. Homologous recombination repair (HRR) is the main mechanism of repair of DNA double-strand breaks. Its deficiency (HRD) is a common featur......

Full Text Link